Clinical-stage biotech company Clearmind Medicine (NASDAQ:CMND) has successfully completed the dosing of all 24 healthy participants in Part A of its FDA-regulated Phase I/II trial evaluating its proprietary compound, CMND-100, for the treatment of Alcohol Use Disorder.
"What the market wants to see is evidence that the Bank of Japan is not behind the curve on inflation," says Jane Foley, head of FX strategy at Rabobank, as the BOJ raised its benchmark interest rate by a quarter percentage point to 1%.
Solana Company (NASDAQ:HSDT) rejected an unsolicited all-stock acquisition proposal from Forward Industries (NASDAQ:FWDI) valuing the business at $1.48 per share.
Clinical-stage biopharmaceutical firm HCW Biologics (NASDAQ:HCWB) reported positive preliminary human data from its Phase 1 trial of HCW9302, revealing that all three mild alopecia areata patients in the 3 μg/kg cohort achieved a 25% or greater reduction in SALT scores.
NovaBridge Biosciences (NASDAQ:NBP) received FDA Fast Track Designation for its bispecific antibody givastomig to treat advanced gastric adenocarcinoma expressing Claudin 18.2 protein levels.
Trinity Biotech (NASDAQ:TRIB) secured new purchase orders for over 2 million HIV tests to support its annual financial objectives.
Zai Lab (NASDAQ:ZLAB) has received European orphan drug designation for its antibody-drug conjugate targeting 375,000 annual lung cancer cases.
Nebius (NASDAQ:NBIS) completed its corporate acquisition of model optimization developer Eigen AI on June 10, 2026.
Vince Holding (NASDAQ:VNCE) reported a 10.5% increase in first-quarter net sales to $64 million, driven by expansion across its direct-to-consumer and wholesale segments.
Edgewise Therapeutics (NASDAQ:EWTX) reported positive 12-week Phase 2 data evaluating its investigational heart disease treatment called EDG-7500.
Invivyd (NASDAQ:IVVD) completed enrollment in its Phase 3 LIBERTY trial to evaluate a potential COVID-19 prevention option.
Robinhood Markets (NASDAQ:HOOD) announced a 10% workforce reduction to maintain its long-term corporate agility and efficiency.
_1422282_640x360_2503767619817-640x360.webp&w=3840&q=75)
-640x360.webp&w=3840&q=75)
